{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:59:30Z","timestamp":1790441970715,"version":"4.1.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021310","name":"Nigerian Institute of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Protein Expression and Purification"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.pep.2026.106982","type":"journal-article","created":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T13:25:10Z","timestamp":1785072310000},"page":"106982","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Expression and immunoassay assessment of immunomodulatory PanDR and SARS-CoV-2 receptor-binding domain antigen in bacteria host cell"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3949-5614","authenticated-orcid":false,"given":"Rukayat Olajumoke","family":"Onilegbale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbemisola Morounke","family":"Saibu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habeeb Adebodun","family":"Bankole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca Oziohu","family":"Omosimua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muinah Adenike","family":"Fowora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayorinde Babatunde","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pep.2026.106982_bib1","series-title":"World Report on Knowledge for Better Health: Strengthening Health Systems","year":"2004"},{"key":"10.1016\/j.pep.2026.106982_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fitd.2023.1180606","article-title":"Grand challenges in major tropical diseases: part II","volume":"4","author":"Menezes","year":"2023","journal-title":"Front. Trop. Dis."},{"key":"10.1016\/j.pep.2026.106982_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.126829","article-title":"Advancing local manufacturing capacities for vaccines within Africa\u2013Opportunities, priorities and challenges","volume":"50","author":"Doua","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2026.106982_bib4","series-title":"Genetic Diversity of Coronaviruses: from SARSCoV to SARS-CoV-2\u2013(Part 2)","first-page":"58","article-title":"History of SARS-CoV-2","author":"Rafiq","year":"2025"},{"key":"10.1016\/j.pep.2026.106982_bib5","series-title":"Middle East Respiratory Syndrome (MERS). Rising Contagious Diseases: Basics, Management, and Treatments","first-page":"164","author":"Arslan","year":"2024"},{"issue":"2","key":"10.1016\/j.pep.2026.106982_bib6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/s41423-023-01095-w","article-title":"B-cell and antibody responses to SARS-CoV-2: infection, vaccination, and hybrid immunity","volume":"21","author":"Lapuente","year":"2024","journal-title":"Cell. Mol. Immunol."},{"issue":"9","key":"10.1016\/j.pep.2026.106982_bib7","article-title":"Detection of SARS-CoV-2 in Nigeria: laboratory preparedness and report of index case","volume":"5","author":"James","year":"2021","journal-title":"PAMJ-One Health"},{"issue":"4","key":"10.1016\/j.pep.2026.106982_bib8","doi-asserted-by":"crossref","first-page":"821","DOI":"10.3390\/cells10040821","article-title":"Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19","volume":"10","author":"Yadav","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.pep.2026.106982_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173455","article-title":"Angiotensin-converting enzyme 2 (ACE2) receptor and SARS-CoV-2: potential therapeutic targeting","volume":"884","author":"Sharifkashani","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pep.2026.106982_bib10","first-page":"51","article-title":"SARS-CoV-2 transmission channels: a review of the literature","volume":"22","author":"El-Wahab","year":"2021","journal-title":"MEDICC review"},{"issue":"10","key":"10.1016\/j.pep.2026.106982_bib11","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.3390\/vaccines9101195","article-title":"Emerging SARS-CoV-2 variants: a review of its mutations, its implications and vaccine efficacy","volume":"9","author":"Ramesh","year":"2021","journal-title":"Vaccines."},{"issue":"1","key":"10.1016\/j.pep.2026.106982_bib12","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1080\/14760584.2023.2211153","article-title":"Advances in SARS-CoV-2 receptor-binding domain-based COVID-19 vaccines","volume":"22","author":"Guan","year":"2023","journal-title":"Expert Rev. Vaccine"},{"issue":"1","key":"10.1016\/j.pep.2026.106982_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/8160860","article-title":"The current status and challenges in the development of vaccines and drugs against Severe Acute Respiratory Syndrome\u2010Corona Virus\u20102 (SARS\u2010CoV\u20102)","volume":"2021","author":"Beeraka","year":"2021","journal-title":"BioMed Res. Int."},{"issue":"5","key":"10.1016\/j.pep.2026.106982_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.13031\/ja.15660","article-title":"A scoping review of postharvest losses, supply chain management, and technology: implications for produce quality in developing countries","volume":"67","author":"Kaur","year":"2024","journal-title":"Journal of the ASABE"},{"issue":"16","key":"10.1016\/j.pep.2026.106982_bib15","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1016\/j.vaccine.2021.03.038","article-title":"mRNA vaccines manufacturing: challenges and bottlenecks","volume":"39","author":"Rosa","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.pep.2026.106982_bib16","series-title":"Reverse Vaccinology","first-page":"41","article-title":"Development of subunit vaccine: a step forward toward cost-effective technology of vaccine candidate discovery","author":"Waseem","year":"2024"},{"key":"10.1016\/j.pep.2026.106982_bib17","doi-asserted-by":"crossref","first-page":"608","DOI":"10.3390\/vaccines10040608","article-title":"COVID-19 vaccines: current and future perspectives","volume":"10","author":"Soraci","year":"2022","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.pep.2026.106982_bib18","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/cmdc.201200487","article-title":"Modern subunit vaccines: development, components, and research opportunities","volume":"8","author":"Moyle","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.pep.2026.106982_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3389\/fimmu.2020.00283","article-title":"Designs of antigen structure and composition for improved protein-based vaccine efficacy","volume":"11","author":"Saylor","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.pep.2026.106982_bib20","first-page":"123","article-title":"The impact of bioinformatics on vaccine design and development","author":"Arturo","year":"2017","journal-title":"Vaccines"},{"issue":"3","key":"10.1016\/j.pep.2026.106982_bib21","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.imlet.2004.01.006","article-title":"The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate","volume":"92","author":"Rosa","year":"2004","journal-title":"Immunol. Lett."},{"issue":"11","key":"10.1016\/j.pep.2026.106982_bib22","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1093\/intimm\/dxl085","article-title":"Novel pan-DR-binding T cell epitopes of adenovirus induce pro-inflammatory cytokines and chemokines in healthy donors","volume":"18","author":"Haveman","year":"2006","journal-title":"Int. Immunol."},{"key":"10.1016\/j.pep.2026.106982_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2022.113279","article-title":"Non-glycosylated SARS-CoV-2 RBD elicited a robust neutralizing antibody response in mice","volume":"506","author":"Ke","year":"2022","journal-title":"J. Immunol. Methods"},{"issue":"1","key":"10.1016\/j.pep.2026.106982_bib24","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/vaccines11010042","article-title":"Unglycosylated soluble SARS-CoV-2 receptor binding domain (RBD) produced in E. coli combined with the army liposomal formulation containing QS21 (ALFQ) elicits neutralizing antibodies against mismatched variants","volume":"11","author":"Balasubramaniyam","year":"2022","journal-title":"Vaccines"},{"issue":"6","key":"10.1016\/j.pep.2026.106982_bib25","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/sj.mt.6300121","article-title":"DNA vaccines encoding Ii-PADRE generates potent PADRE-specific CD4+ T-cell immune responses and enhances vaccine potency","volume":"15","author":"Hung","year":"2007","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.pep.2026.106982_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0264-410X(97)00186-2","article-title":"Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo","volume":"15","author":"Del Guercio","year":"1997","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.pep.2026.106982_bib27","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.vaccine.2010.12.124","article-title":"Recombinant heat shock protein 65 carrying PADRE and HBV epitopes activates dendritic cells and elicits HBV-specific CTL responses","volume":"29","author":"Wang","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.pep.2026.106982_bib28","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.3390\/ijms23084341","article-title":"Identification of B-cell epitopes for eliciting neutralizing antibodies against the SARS-CoV-2 spike protein through bioinformatics and monoclonal antibody targeting","volume":"23","author":"Lim","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"49","key":"10.1016\/j.pep.2026.106982_bib29","doi-asserted-by":"crossref","first-page":"eabd6160","DOI":"10.1126\/sciimmunol.abd6160","article-title":"SARS-CoV-2 T cell immunity: specificity, function, durability, and role in protection","volume":"5","author":"Altmann","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.pep.2026.106982_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2021.104970","article-title":"Design, expression, and purification of a multi-epitope vaccine against Helicobacter Pylori based on Melittin as an adjuvant","volume":"157","author":"Jafari","year":"2021","journal-title":"Microb. Pathog."},{"issue":"18","key":"10.1016\/j.pep.2026.106982_bib31","doi-asserted-by":"crossref","first-page":"14085","DOI":"10.1021\/acs.chemrev.1c00757","article-title":"Protein design: from the aspect of water solubility and stability","volume":"122","author":"Qing","year":"2022","journal-title":"Chem. Rev."},{"issue":"1","key":"10.1016\/j.pep.2026.106982_bib32","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/s41541-021-00393-6","article-title":"Scientific rationale for developing potent RBD-based vaccines targeting COVID-19","volume":"6","author":"Kleanthous","year":"2021","journal-title":"npj Vaccines"},{"key":"10.1016\/j.pep.2026.106982_bib33","article-title":"A Survey of deep learning methods in protein bioinformatics and its impact on protein design","author":"Dai","year":"2025","journal-title":"arXiv preprint arXiv:250101477"}],"container-title":["Protein Expression and Purification"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592826001051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1046592826001051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T16:32:52Z","timestamp":1790440372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1046592826001051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":33,"alternative-id":["S1046592826001051"],"URL":"https:\/\/doi.org\/10.1016\/j.pep.2026.106982","relation":{},"ISSN":["1046-5928"],"issn-type":[{"value":"1046-5928","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression and immunoassay assessment of immunomodulatory PanDR and SARS-CoV-2 receptor-binding domain antigen in bacteria host cell","name":"articletitle","label":"Article Title"},{"value":"Protein Expression and Purification","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pep.2026.106982","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106982"}}